Chargement en cours...
Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
The heterogeneity of symptoms and disease progression observed in synucleinopathies, of which Parkinson’s disease (PD) is the most common representative, poses large problems for the discovery of novel therapeutics. The molecular basis for pathology is currently unclear, both in familial and in spor...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Libertas Academica
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2746575/ https://ncbi.nlm.nih.gov/pubmed/19787096 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|